GURUFOCUS.COM » STOCK LIST » Oceania » Australia » ASX » Prescient Therapeutics Ltd (ASX:PTX) » Definitions » Float Percentage Of Total Shares Outstanding
Switch to:

Prescient Therapeutics (ASX:PTX) Float Percentage Of Total Shares Outstanding

: 0.00% (As of Today)
View and export this data going back to 1986. Start your Free Trial

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Prescient Therapeutics's float shares is 0.00 Mil. Prescient Therapeutics's total shares outstanding is 725.77 Mil. Prescient Therapeutics's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Prescient Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Prescient Therapeutics's Institutional Ownership is 0.20%.

Prescient Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Prescient Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/725.77
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prescient Therapeutics (ASX:PTX) Business Description

Prescient Therapeutics logo
Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prescient Therapeutics Ltd (ASX:PTX) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
ASX:PAB ASX:OCC ASX:RAD ASX:CYP ASX:BOT ASX:DXB ASX:BNO ASX:AGN ASX:VBS ASX:IXC OCSE:NOVO B ASX:CSL NAS:REGN NAS:VRTX NAS:MRNA XKRX:207940 NAS:BNTX NAS:SGEN HKSE:02269 OCSE:GMAB
Traded in Other Exchanges
N/A
Address
Level 4, 100 Albert Road, South Melbourne, Melbourne, VIC, AUS, 3205
Website
https://www.ptxtherapeutics.com
Prescient Therapeutics Ltd is a clinical-stage oncology company. The company develops novel compounds for the treatment of a range of cancers in Australia. Its product in the pipeline includes OmniCAR; PTX-100 and PTX-200. OmniCAR is a universal immune receptor platform enabling controllable T-cell activity and multi-antigen targeting with a single cell product.

Prescient Therapeutics (ASX:PTX) Headlines

No Headlines